Modulation of Tumor Suppressor Genes by Histone Deacetylase Inhibitors in Cancer Therapy
Sung-Kun Kim, Nicol L. Nightingale, Kong K. Lee, Connor M. Ferlazzo, Lydia E. Neff & Jatindra N. Tripathy · Journal of Pharmaceutical Research International · 2024
Histone deacetylase (HDAC) inhibitors have emerged as promising therapeutics for various cancers due to their ability to modulate gene expression profiles and restore normal cellular functions. Among the key targets of HDAC inhibitors are tumor suppressor genes, which play crucia...
Open access
Research Article
10.9734/jpri/2024/v36i117596